Pan-Cancer Proteomics Analysis Reveals Wiskott–Aldrich Syndrome Protein as a Potential Regulator of Programmed Death-Ligand 1-Reference-Cited by-同舟云学术

Pan-Cancer Proteomics Analysis Reveals Wiskott–Aldrich Syndrome Protein as a Potential Regulator of Programmed Death-Ligand 1

Published:2024-04-25 Issue:6 Volume:23 Page:2195-2205
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Hu Liling¹^ORCID,Liu Danya¹,Zheng Dandan¹,Lu Jiangli²,Yuan Xiaoyi¹,Li Yuying¹,Shi Fujin¹,Shi Xinyu¹,He Qing-Yu¹^ORCID,Li Qiuli³,Zhang Chris Zhiyi¹

Affiliation:

1. MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China

2. Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China

3. Department of Head and Neck, Sun Yat-sen University Cancer Center, Guangzhou 510060, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.4c00124

Reference41 articles.

1. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

2. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

3. Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

4. Combined BRAF and MEK inhibition for the treatment of BRAF-mutated metastatic melanoma

5. TKI resistant-based prognostic immune related gene signature in LUAD, in which FSCN1 contributes to tumor progression